1-8 of 8
sodium thiosulfate
Close
Sort by
Journal Articles

More Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells

Naoya Uchida, Fujita Atsushi, Haro-Mora J Juan, Thomas Winkler, MD, John F Tisdale, MD
Journal: Blood
Blood (2015) 126 (23): 1150.
https://doi.org/10.1182/blood.V126.23.1150.1150
Published: 2015
Journal Articles

An Optimized, Large Scale Generation and Validation of Aspergillus-Specific T Lymphocytes for the Management of Invasive Aspergillosis in Immunocompromised Patients

Anastasia Papadopoulou, PhD, Panayotis Kaloyannidis, MD, Maria Alvanou, Joanne Kalogeropoulou, Achilles Anagnostopoulos, Evangelia Yannaki, MD
Journal: Blood
Blood (2015) 126 (23): 4293.
https://doi.org/10.1182/blood.V126.23.4293.4293
Published: 2015
Journal Articles

Risks for Different Neoplasms (DNs) in Multiple Myeloma (MM) Patients May Involve Specific Host-, Myeloma- and Treatment-Related Susceptibilities: Registry Data of 681 Consecutive MM Patients,

Martina Kleber, Kerstin Höck, Gabriele Ihorst, Bernd Koch, Ralph Waesch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2011) 118 (21): 3929.
https://doi.org/10.1182/blood.V118.21.3929.3929
Published: 2011
Journal Articles

Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma

Brief Report
Alison J. Moskowitz, Joachim Yahalom, Tarun Kewalramani, Jocelyn C. Maragulia, Jill M. Vanak, Andrew D. Zelenetz, Craig H. Moskowitz
Journal: Blood
Blood (2010) 116 (23): 4934–4937.
https://doi.org/10.1182/blood-2010-05-282756
Published: 2010
Journal Articles

2006 RADAR Report Card on Conversion Rates from Accelerated FDA Approval to Regular FDA Approval for Drugs Used To Treat Hematologic Malignancies: Policy Changes Continue To Be Needed.

Andrew J. Lurie, BGS, Mark V. Mai, Martin S. Tallman, MD, June McCoy, MD JD MPH, Charles L. Bennett, MD PhD MPP
Journal: Blood
Blood (2006) 108 (11): 3318.
https://doi.org/10.1182/blood.V108.11.3318.3318
Published: 2006
Journal Articles

Cellular Localization Pattern of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) in a Patient with Low-Grade Non-Hodgkin’s Lymphoma (NHL).

Samuel A. Jacobs, MD, Anthony M. Harrison, MD, Steven H. Swerdlow, MD, Kenneth A. Foon, MD, Norbert Avril, MD, Nick Vidnovic, Kenneth S. McCarty, MD, PHD, Wayne Saville, MD
Journal: Blood
Blood (2004) 104 (11): 4569.
https://doi.org/10.1182/blood.V104.11.4569.4569
Published: 2004
Journal Articles

Individualized risks of first adverse events in patients with Fanconi anemia

Clinical Trials & Observations
Philip S. Rosenberg, Yi Huang, Blanche P. Alter
Journal: Blood
Blood (2004) 104 (2): 350–355.
https://doi.org/10.1182/blood-2004-01-0083
Published: 2004
Journal Articles

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

Clinical Trials & Observations
Didier Blaise, Jacques Olivier Bay, Catherine Faucher, Mauricette Michallet, Jean-Michel Boiron, Bachra Choufi, Jean-Yves Cahn, Nicole Gratecos, Jean-Jacques Sotto, Sylvie François, Joel Fleury, Mohamad Mohty, Christian Chabannon, Karin Bilger, Gwenaelle Gravis, Frédéric Viret, Anne Chantal Braud, Valérie Jeanne Bardou, Dominique Maraninchi, Patrice Viens
Journal: Blood
Blood (2004) 103 (2): 435–441.
https://doi.org/10.1182/blood-2003-07-2236
Published: 2004